Replies to post #222602 on Biotech Values

[n4807g]

tiered low-double-digit to high-teen royalty payments on future net sales

That's impressive.

[DewDiligence]

Fosun subsidiary wins China approval for Rituxan biosimilar:

https://www.fiercepharma.com/pharma-asia/china-approves-its-first-biosimilar-by-fosun-s-ipo-heading-henlius-and-to-roche-s